Cas:1315364-91-0 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid manufacturer & supplier

Chemical Name:5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid

CAS.NO:1315364-91-0

Synonyms:5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid

Molecular Formula:C₇H₄ClN₃O₂

Molecular Weight:197.57900

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:67.49000

Exact Mass:196.99900

LogP:1.08090

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid Use and application,5-Chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid technical grade,usp/ep/jp grade.

Related News: The fine and functional chemicals sector provides new growth drivers. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid supplier With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China. 5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylic acid factory With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.